Famciclovir


Generic Medicine Info
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to famciclovir and penciclovir.
Special Precautions
Renal impairment. Pregnancy and lactation. Patient Counselling This drug may cause dizziness, somnolence, confusion or other CNS disturbances, if affected, do not drive or operate machinery. Avoid sexual intercourse when symptoms of genital herpes are present. Monitoring Parameters Monitor haematological function.
Adverse Reactions
Headache, nausea, diarrhoea, fatigue, dizziness, fever, paraesthesia, somnolence, vomiting, constipation, anorexia, abdominal pain, flatulence, dyspepsia; increased serum levels of ALT, alkaline phosphatase, total bilirubin and albumin; pruritus, pharyngitis, sinusitis, injury, generalised pain, rigors, back pain, arthralgia; increased serum phosphate, Na and K levels; abnormal leukocyte counts, purpura, angioedema.
Potentially Fatal: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis.
Drug Interactions
Reduced renal excretion resulting to increased plasma concentration w/ probenecid. Raloxifen may reduce the formation of penciclovir, the active metabolite of famciclovir.
CIMS Class
ATC Classification
S01AD07 - famciclovir ; Belongs to the class of antiinfectives, antivirals. Used in the treatment of eye infections.
J05AB09 - famciclovir ; Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
Disclaimer: This information is independently developed by CIMS based on famciclovir from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in